BXRX News and Press, Baudax Bio Inc.

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...

Baudax Bio Inc. (BXRX) is expected to report $-0.53 for Q3 2023

2023-10-18 12:14:27 ET DENVER, Colo., Oct. 18, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Treasure Global Inc (NASDAQ: TGL), SeaStar Medical Holding Corp (NASDAQ: ICU), Mainz Biomed NV (NASDAQ...

2023-10-18 10:05:13 ET DENVER, Colo., Oct. 18, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Ardelyx Inc (NASDAQ: ARDX) Treasure Global Inc (NASDAQ: TGL), SeaStar Medical Holding Corp (NASDAQ: ICU), Mai...

Company Poised to Initiate TI-168 Clinical Development Following Recent Shareholder Approval of Corporate Actions Related to TeraImmune Acquisition Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024 MALVERN, Pa., Oct. 18, 2023 (GLO...

2023-09-29 06:31:00 ET Is Short or Long Term Investing in Penny Stocks Better? Investing in penny stocks offers a spectrum of opportunities, with the potential for significant returns. A pivotal consideration for investors is determining the optimal investment horizon—whether to ...

2023-09-28 09:53:32 ET DENVER, Colo., Sept 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Bionomics (NASDAQ: BNOX), Baudax Bio (NASDAQ: BXRX), Gritstone Bio (NASDAQ: GRTS), Chico’s FAS (NYSE: ...

2023-09-28 08:43:07 ET (24/7 MARKET NEWS) – Baudax Bio, Inc. (NASDAQ: BXRX) stated, this morning, that U.S. Food and Drug Administration (FDA) granted orphan drug designation to its lead clinical candidate TI-168 for the treatment of Hemophilia A with inhibitors. TI-168 is the Compan...

MALVERN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a biotechnology company focused on developing T cell receptor (“TCR”) therapies utilizing human regulatory T cells (“Tregs”), a...